findmyKOL

Robert Lisak, MD

Basic profile

Wayne State University

ORCIDNone on fileNPI
RegionDetroit, MI · MidwestSpecialtyNeurologyFocusNeurology
Last active 2023findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH funding1987–2020Why? →

Robert Lisak is a Neurology physician affiliated with Wayne State University. OpenAlex indexes 431 publications with 17,668 citations (h-index 65). By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
431publications

Distinct works indexed by OpenAlex.

17,668citations

Total citations across indexed works.

65h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
5NIH grants · 1987–2020

Federally funded research awards.

View funding

Industry payments

4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

4 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    45.2%
    Other immunostimulants34.4%
    Copaxone64%Glatiramer Acetate19%Glatopa17%
    Part D<11 patients
    Complement Inhibitor10.8%
    Soliris100%
    Part D<11 patients
  • Nervous system

    29.6%
    Cholinesterase Inhibitor23.7%
    Pyridostigmine Bromide75%Pyridostigmine Bromide Er25%
    Part D<11 patients
    Gabapentinoids5.9%
    Gabapentin100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    16.7%
    Corticosteroid16.7%
    Prednisone100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

5 NIH research awards on record, funded 19872020 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”